Proceedings of the International Conference on Sustainable Innovation on Health Sciences and Nursing (ICOSI-HSN 2022)

<Previous Article In Volume
Next Article In Volume>

Interferon-Gamma Level and Affecting Factor in DM Patients at Public Health Center

Authors
Akrom Akrom1, 4, *, Titiek Hidayati2, Arif Budisetianto3
1Pharmacology and Clinical Pharmacy Department, Universitas Ahmad Dahlan, Yogyakarta, Indonesia
2Public Health and Family Medicine Department, Medicine and Health Faculty, Universitas Muhammadiyah Yogyakarta, Yogyakarta, Indonesia
3Pharmaceutical Technology Department, Universitas Ahmad Dahlan, Yogyakarta, Indonesia
4Ahmad Dahlan Drug Information and Research Center, Yogyakarta, Indonesia
*Corresponding author. Email: akrom@pharm.uad.ac.id
Corresponding Author
Akrom Akrom
Available Online 26 December 2022.
DOI
10.2991/978-94-6463-070-1_11How to use a DOI?
Keywords
diabetes mellitus; IFN-γ levels; blood sugar levels; primary health care
Abstract

The study aims to understand the interferon-gamma (IFN-γ) level and affecting factors in diabetes mellitus (DM) patients at Public Health Center (PHC). This cross-sectional study was conducted on 153 DM patients. The inclusion criteria were male or female patients over 18 years old diagnosed with DM for three months. They stated their willingness to study Interviews were conducted to obtain exercise habits data. We carried out laboratory measurements of random blood sugar(RBS), triglycerides TG, and IFN-γ. Data are presented descriptively and analytically. Most subjects were women with no smoking, hyperglycemia, and hypertriglyceridemia. RBS and TG were higher than the target, 257.88 ± 117.76 mg/dl and 204.66 ± 103.83 mg/dl, respectively. Hemoglobin (Hb) (12.95 ± 1.49), leukocyte (8.96 ± 1.96), platelet (321.24 ± 0.74), and erythrocytes (4.53 ± 0.55) were normal. There was no difference in IFN-γ levels based on gender, age group, obesity status, hyperglycemia status, hypertriglyceridemia, and hypertension status. Conclusion: There was no difference in IFN-γ levels based on demographic and clinical characteristics in DM patients at the JPHC.

Copyright
© 2022 The Author(s)
Open Access
Open Access This chapter is licensed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), which permits any noncommercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license and indicate if changes were made.

Download article (PDF)

<Previous Article In Volume
Next Article In Volume>
Volume Title
Proceedings of the International Conference on Sustainable Innovation on Health Sciences and Nursing (ICOSI-HSN 2022)
Series
Advances in Health Sciences Research
Publication Date
26 December 2022
ISBN
978-94-6463-070-1
ISSN
2468-5739
DOI
10.2991/978-94-6463-070-1_11How to use a DOI?
Copyright
© 2022 The Author(s)
Open Access
Open Access This chapter is licensed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), which permits any noncommercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license and indicate if changes were made.

Cite this article

risenwbib
TY  - CONF
AU  - Akrom Akrom
AU  - Titiek Hidayati
AU  - Arif Budisetianto
PY  - 2022
DA  - 2022/12/26
TI  - Interferon-Gamma Level and Affecting Factor in DM Patients at Public Health Center
BT  - Proceedings of the International Conference on Sustainable Innovation on Health Sciences and Nursing (ICOSI-HSN 2022)
PB  - Atlantis Press
SP  - 75
EP  - 82
SN  - 2468-5739
UR  - https://doi.org/10.2991/978-94-6463-070-1_11
DO  - 10.2991/978-94-6463-070-1_11
ID  - Akrom2022
ER  -